Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.

Shares of Ross Stores, Inc. ROST surged during Friday’s session as the company reported upbeat results for its third quarter and raised FY23 earnings guidance.

Ross Stores reported quarterly earnings of $1.33 per share, surpassing estimates of $1.21, representing a 33% increase over earnings of $1.00 per share from the same period last year. Revenue clocked in at $4.92 billion, above the analyst consensus estimate of $4.82 billion, according to data from Benzinga Pro.

The company raised its full-year 2023 earnings per share outlook from between $5.15 and $5.26 to between $5.30 and $5.36.

Ross Stores shares climbed 8.8% to $130.67 on Friday.

Here are some big stocks recording gains in today’s session.

• The Gap, Inc. GPS shares jumped 26.9% to $17.35 after the company reported better-than-expected financial results for the third quarter on Thursday.
• Twist Bioscience Corporation TWST surged 20.2% to $22.93 following strong quarterly results.
• Qifu Technology, Inc. QFIN shares rose 14% to $17.66 following third-quarter results.
• GDEV Inc. GDEV climbed 13.2% to $3.00.
• VNET Group, Inc. VNET gained 13% to $2.95.
• Caribou Biosciences, Inc. CRBU surged 12.4% to $5.32.
• Icosavax, Inc. ICVX rose 11.2% to $10.36. Guggenheim initiated coverage on Icosavax with a Buy rating and announced a price target of $28.
• Globant S.A. GLOB jumped 12.4% to $205.73 following upbeat third-quarter results.
• Brookdale Senior Living Inc. BKD rose 11.2% to $5.03. RBC Capital upgraded Brookdale Senior Living from Sector Perform to Outperform and raised the price target from $7 to $9.
• Tenet Healthcare Corporation THC gained 11% to $64.60 after it inked a deal with Novant Health to sell three hospitals and related operations in South Carolina for around $2.4 billion in cash.
• CRISPR Therapeutics AG CRSP gained 8.4% to $64.50. CRISPR Therapeutics recently announced regulatory authorization of the first CRISPR/Cas9 gene-edited therapy.
• Manchester United plc MANU gained 7.4% to $19.79 following a report suggesting Jim Ratcliffe's Ineos Sports is in talks to buy a 25% stake in the club for $33 per share.
• Abercrombie & Fitch Co. ANF gained 7.4% to $74.10.
• The Buckle, Inc. BKE rose 7.3% to $37.50 following upbeat earnings.

Now Read This: Jim Cramer Has A 'Problem' With This Fintech Giant: 'I Like The Mastercards And The Visas Now'